Completed NA INTERVENTIONAL 2-arm NCT01096550

Intensive Outpatient Versus Outpatient Treatment With Buprenorphine Among African Americans

Intensive Outpatient v. Outpatient Treatment With Buprenorphine Among African Americans

Sponsor: Friends Research Institute, Inc.

Interventions Intensive Outpatient Outpatient

Updated 8 times since 2017 Last updated: Mar 31, 2020 Started: Mar 31, 2010 Primary completion: Oct 31, 2011 Completion: Oct 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01096550, this NA trial focuses on Drug Dependence and remains completed. Sponsored by Friends Research Institute, Inc., it has been updated 8 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Dec 2021 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Dec 2021 [monthly]

Completed NA
May 2020 — Jan 2021 [monthly]

Completed NA

▶ Show 3 earlier versions

Mar 2020 — May 2020 [monthly]

Completed NA

Phase: PHASE4 → NA
Jun 2018 — Mar 2020 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Mar 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Data source: Friends Research Institute, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States